home / stock / ettx / ettx quote
Last: | $2.19 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $2.19 |
High: | $0 |
Low: | $0 |
Volume: | 800 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.19 | $0 | $2.19 | $0 | $0 | 800 | 08-05-2022 |
$2.19 | $2.19 | $2.19 | $2.2 | $2.19 | 68,834 | 07-08-2022 |
$2.2 | $2.19 | $2.2 | $2.2 | $2.19 | 10,635 | 07-07-2022 |
$2.19 | $2.19 | $2.19 | $2.2 | $2.19 | 57,760 | 07-06-2022 |
$2.19 | $2.18 | $2.19 | $2.2 | $2.18 | 214,965 | 07-05-2022 |
$2.19 | $2.2 | $2.19 | $2.2 | $2.19 | 49,346 | 07-04-2022 |
$2.19 | $2.2 | $2.19 | $2.2 | $2.19 | 49,346 | 07-01-2022 |
$2.2 | $2.18 | $2.2 | $2.2 | $2.18 | 104,204 | 06-30-2022 |
$2.19 | $2.19 | $2.19 | $2.2 | $2.18 | 237,952 | 06-29-2022 |
$2.19 | $2.19 | $2.19 | $2.2 | $2.19 | 31,675 | 06-28-2022 |
$2.19 | $2.19 | $2.19 | $2.2 | $2.19 | 25,739 | 06-27-2022 |
$2.2 | $2.18 | $2.2 | $2.2 | $2.18 | 109,705 | 06-24-2022 |
$2.2 | $2.19 | $2.2 | $2.2 | $2.1801 | 79,889 | 06-23-2022 |
$2.19 | $2.18 | $2.19 | $2.195 | $2.18 | 47,657 | 06-22-2022 |
$2.18 | $2.19 | $2.18 | $2.2 | $2.18 | 57,178 | 06-21-2022 |
$2.19 | $2.18 | $2.19 | $2.19 | $2.18 | 170,283 | 06-20-2022 |
$2.19 | $2.18 | $2.19 | $2.19 | $2.18 | 170,283 | 06-17-2022 |
$2.19 | $2.18 | $2.19 | $2.19 | $2.18 | 137,907 | 06-16-2022 |
$2.18 | $2.18 | $2.18 | $2.19 | $2.18 | 302,682 | 06-15-2022 |
$2.18 | $2.18 | $2.18 | $2.19 | $2.18 | 148,677 | 06-14-2022 |
News, Short Squeeze, Breakout and More Instantly...
Entasis Therapeutics Holdings Inc. Company Name:
ETTX Stock Symbol:
NASDAQ Market:
Entasis Therapeutics Holdings Inc. Website:
WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. , a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced ...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”) at a price of $2.20 per share, net to the s...
WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced multiple presentations at the American Society...